Contrasting effects of nitric oxide and corticotropin-releasing factor within the dorsal periaqueductal gray on defensive behavior and nociception in mice

Brazilian Journal of Medical and Biological Research

Volumn 45, Issue 4, 2012, Pages 299-307

  Miguel, T T ^a,b   Gomes, K S ^b   Nunes de Souza, R L ^a,b  

^a FEDERAL UNIVERSITY OF SÃO CARLOS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Antinociception; Corticotropin releasing factor; Defensive behavior; Mice; Nitric oxide; Periaqueductal gray

Indexed keywords

5 CHLORO 4 [N (CYCLOPROPYLMETHYL) N PROPYLAMINO] 2 METHYL 6 (2,4,6 TRICHLOROANILINO)PYRIMIDINE; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; FORMALDEHYDE; N(G) PROPYLARGININE; NITRIC OXIDE DONOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTINOCICEPTION; ANXIETY; ARTICLE; CANNULA; CONTROLLED STUDY; DEFENSIVE BEHAVIOR; JUMPING; MALE; MOUSE; NONHUMAN; PERIAQUEDUCTAL GRAY MATTER; RUNNING; STEREOTACTIC PROCEDURE;

MUS;

EID: 84859588114     PISSN: 0100879X     EISSN: 1414431X     Source Type: Journal    
DOI: 10.1590/S0100-879X2012007500043     Document Type: Article

References (38)

1. Miguel TT, Nunes-de-Souza RL. Defensive-like behaviors and antinociception induced by NMDA injection into the pe-riaqueductal gray of mice depend on nitric oxide synthesis. Brain Res 2006; 1076: 42-48.
2. Schenberg LC, Povoa RM, Costa AL, Caldellas AV, Tufik S, Bittencourt AS. Functional specializations within the tectum defense systems of the rat. Neurosci Biobehav Rev 2005; 29: 1279-1298.
3. Blanchard DC, Hynd AL, Minke KA, Minemoto T, Blanchard RJ. Human defensive behaviors to threat scenarios show parallels to fear- and anxiety-related defense patterns of non-human mammals. Neurosci Biobehav Rev 2001; 25: 761-770.
4. Siegfried B, Frischknecht HR, Nunes de Souza RL. An ethological model for the study of activation and interaction of pain, memory and defensive systems in the attacked mouse. Role of endogenous opioids. Neurosci Biobehav Rev 1990; 14:481-490.
5. Engin E, Treit D. The effects of intra-cerebral drug infusions on animals' unconditioned fear reactions: a systematic review. Prog Neuropsychopharmacol BiolPsychiatry 2008; 32: 1399-1419.
6. Graeff FG. Serotonin, the periaqueductal gray and panic. Neurosci Biobehav Rev 2004; 28: 239-259.
7. Heresco-Levy U. Glutamatergic neurotransmission modulation and the mechanisms of antipsychotic atypicality. Prog Neuropsychopharmacol Biol Psychiatry 2003; 27: 1113-1123.
8. Bandler R. Brain mechanisms of aggression as revealed by electrical and chemical stimulation: suggestion of a central role for the midbrain periaqueductal gray region. Vol. 13. In: Epstein A, Horrison A (Editors), Progress in psychobiology and physiological psychology. New York: Academic Press; 1988. p 67-154.
9. Garthwaite J, Garthwaite G, Palmer RM, Moncada S. NMDA receptor activation induces nitric oxide synthesis from argi-nine in rat brain slices. Eur J Pharmacol 1989; 172: 413-416.
10. Prast H, Philippu A. Nitric oxide as modulator of neuronal function. Prog Neurobiol 2001; 64: 51-68.
11. Braga AA, Aguiar DC, Guimaraes FS. NOC-9, a selective nitric oxide donor, induces flight reactions in the dorsolateral periaqueductal gray of rats by activating soluble guanylate cyclase. Neurosci Lett 2009; 459: 79-83.
12. Guimaraes FS, Beijamini V, Moreira FA, Aguiar DC, de Lucca AC. Role of nitric oxide in brain regions related to defensive reactions. Neurosci Biobehav Rev 2005; 29: 1313-1322.
13. Carvalho-Netto EF, Gomes KS, Amaral VC, Nunes-de-Souza RL. Role of glutamate NMDA receptors and nitric oxide located within the periaqueductal gray on defensive behaviors in mice confronted by predator. Psychopharmacology 2009; 204: 617-625.
14. Leger L, Charnay Y, Burlet S, Gay N, Schaad N, Bouras C, et al. Comparative distribution of nitric oxide synthase- and serotonin-containing neurons in the raphe nuclei of four mammalian species. Histochem Cell Biol 1998; 110: 517-525.
15. Onstott D, Mayer B, Beitz AJ. Nitric oxide synthase im-munoreactive neurons anatomically define a longitudinal dorsolateral column within the midbrain periaqueductal gray of the rat: analysis using laser confocal microscopy. Brain Res 1993; 610:317-324.
16. Raber J, Koob GF, Bloom FE. lnterleukin-2 (IL-2) induces corticotropin-releasing factor (CRF) release from the amygdala and involves a nitric oxide-mediated signaling; comparison with the hypothalamic response. J Pharmacol Exp Ther 1995; 272: 815-824.
17. Albeck DS, McKittrick CR, Blanchard DC, Blanchard RJ, Ni-kulina J, McEwen BS, et al. Chronic social stress alters levels of corticotropin-releasing factor and arginine vasopressin mRNA in rat brain. J Neurosci 1997; 17: 4895-4903.
18. Blanchard DC, Sakai RR, McEwen B, Weiss SM, Blanchard RJ. Subordination stress: behavioral, brain, and neuroendo-crine correlates. Behav Brain Res 1993; 58: 113-121.
19. Timpl P, Spanagel R, Sillaber I, Kresse A, Reul JM, Stalla GK, et al. Impaired stress response and reduced anxiety in mice lacking a functional corticotropin-releasing hormone receptor 1. Nat Genet 1998; 19: 162-166.
20. Britton DR, Koob GF, Rivier J, Vale W. Intraventricular corticotropin-releasing factor enhances behavioral effects of novelty. Life Sei 1982; 31: 363-367.
21. Martins AP, Marras RA, Guimaraes FS. Anxiogenic effect of corticotropin-releasing hormone in the dorsal periaqueductal grey. A/eworeporf 1997; 8: 3601-3604.
22. Baldwin HA, Rassnick S, Rivier J, Koob GF, Britton KT. CRF antagonist reverses the anxiogenic response to ethanol withdrawal in the rat. Psychopharmacology 1991; 103: 227-232.
23. Martins AP, Marras RA, Guimaraes FS. Anxiolytic effect of a CRH receptor antagonist in the dorsal periaqueductal gray. Depress Anxiety 2000; 12: 99-101.
24. Nishikawa H, Hata T, Itoh E, Funakami Y A role for corticotropin-releasing factor in repeated cold stress-induced anxiety-like behavior during forced swimming and elevated plus-maze tests in mice. Biol Pharm Bull 2004; 27: 352-356.
25. Miguel TT, Nunes-de-Souza RL. Anxiogenic and antinocice-ptive effects induced by corticotropin-releasing factor (CRF) injections into the periaqueductal gray are modulated by CRF1 receptor in mice. Horm Behav 2011 60: 292-300.
26. Lee S, Kim CK, Rivier C. Nitric oxide stimulates ACTH secretion and the transcription of the genes encoding for NGFI-B, corticotropin-releasing factor, corticotropin-releasing factor receptor type 1, and vasopressin in the hypothalamusofthe intact rat. J Neurosci 1999; 19: 7640-7647.
27. Miguel TT, Nunes-de-Souza RL. Anxiogenic-like effects induced by NMDA receptor activation are prevented by inhibition of neuronal nitric oxide synthase in the periaqueductal gray in mice. Brain Res 2008; 1240: 39-46.
28. Paxinos G, Franklin KBJ. The mouse brain in stereotaxic coordinates. California: Academic Press; 2001.
29. Lister RG. The use of a plus-maze to measure anxiety in the mouse. Psychopharmacology 1987; 92: 180-185.
30. Rodgers RJ, Johnson NJ. Factor analysis of spatiotemporal and ethological measures in the murine elevated plus-maze test of anxiety. Pharmacol Biochem Behav 1995; 52: 297-303.
31. Dubuisson D, Dennis SG. The formalin test: a quantitative study of the analgesic effects of morphine, meperidine, and brain stem stimulation in rats and cats. Pain 1977; 4: 161-174.
32. Tjolsen A, Berge OG, Hunskaar S, Rosland JH, Hole K The formalin test: an evaluation of the method. Pain 1992; 51: 5-17.
33. Nedergaard M. Direct signaling from astrocytes to neurons in cultures of mammalian brain cells. Science 1994; 263: 1768-1771.
34. Bowers LK, Swisher CB, Behbehani MM. Membrane and synaptic effects of corticotropin-releasing factor on periaqueductal gray neurons of the rat. Brain Res 2003; 981: 52-57.
35. Aldenhoff JB, Gruol DL, Rivier J, Vale W, Siggins GR. Corti-cotropin releasing factor decreases postburst hyperpolariza-tions and excites hippocampal neurons. Science 1983; 221: 875-877.
36. Fox EA, Gruol DL. Corticotropin-releasing factor suppresses the afterhyperpolarization in cerebellar Purkinje neurons. Neurosci Lett 1993; 149: 103-107.
37. Valentino RJ, Foote SL, Aston-Jones G. Corticotropin-releasing factor activates noradrenergic neurons of the locus coeruleus. Brain Res 1983; 270: 363-367.
38. Skorzewska A, Bidzinski A, Hamed A, Lehner M, Turzynska D, Sobolewska A, et al. The effect of CRF and alpha-helical CRF((9-41)) on rat fear responses and amino acids release in the central nucleus of the amygdala. Neuropharmacology 2009; 57: 148-156.